No Data
No Data
BridgeBio Pharma (BBIO): Among the Best Performing Mid Cap Stocks to Buy According to Analysts
Express News | Form 144 | BridgeBio Pharma(BBIO.US) Director Proposes to Sell 10.88 Million in Common Stocks
Analysts' Top Healthcare Picks: BridgeBio Pharma (BBIO), Madrigal Pharmaceuticals (MDGL)
Leerink Partners Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Announces Target Price $48
Strong Launch and Strategic Initiatives Propel BridgeBio Pharma's Growth Prospects
Express News | BridgeBio Pharma Inc - Proceeds to Repay and Terminate Financing Agreement